Medtronic plc Stock News

The top tech stocks are always a point of contention among investors. Some prefer sticking with reliable companies like the Magnificent 7, while others decry the same for being grossly overvalued.

Medtronic is a well-diversified healthcare company with strong secular growth and pricing power. The company has four major business segments, each contributing over $2 billion in annual revenue. Medt

In my monthly series of 10 Dividend Growth Stocks, I rank a selection of Dividend Radar stocks and present the 10 top-ranked stocks for further research and possible investment. This month, I'm presen

The stock market is enjoying some holiday cheer. Amid signs that inflation is letting up and the Federal Reserve may finally put an end to its rate hikes, traders are piling into all sorts of investme

Medtronic has a history of raising its dividend rapidly, but its pace has slowed down. Fiscal second-quarter sales earnings fell slightly, and the company's predictions for the next six months aren't

Medtronic (NYSE: MDT) recently reported its Q2 fiscal 2024 results (fiscal ends in April), with revenues and earnings beating our estimates, and we believe that MDT st

Chevron's growing dividend has enabled it to produce enriching returns. Coca-Cola's ability to grow hasn't fizzled out.

Medtronic has been working to get key products across the finish line. The company is jettisoning slower-growing divisions so it can focus on growth.

After two years of correction and downtrend, providing ample incentive to buyers all along the way, medical device maker Medtronic NYSE: MDT has finally reached its bottom, and the reversal is on. The

The medical-devices specialist published its latest set of quarterly results. Happily for its shareholders, the company managed to grow on both the top and bottom lines and beat analyst estimates.

Geoff Martha, Medtronic CEO, joins 'Closing Bell Overtime' to talk quarterly results, the impact of weight-loss drugs, and more.

Medtronic (MDT) Q2 results reflect broad strength across businesses and geographies, benefiting from durable fundamentals.

Medtronic PLC (NYSE:MDT) shares moved higher in early trade on Tuesday as the medical devices company raised its fiscal 2024 sales and profit guidance. For the full year ending in April 2024, it expec

Medtronic PLC's stock MDT rose 0.8% premarket Tuesday, after the medical device maker posted better-than-expected earnings for its fiscal second quarter and raised guidance. Dublin-based Medtronic pos

Medtronic on Tuesday raised its annual profit forecast for the second time this year, banking on higher demand for its medical devices as surgery volumes pick up pace.